The invention relates to the field of Arteriviruses and vaccines directed against infections caused by these viruses. The invention provides an Arterivirus-like particle comprising at least a first structural protein derived from a first Arterivirus and a second structural protein wherein said second structural protein is at least partly not derived from said first Arterivirus.